​
​

Context Therapeutics (CNTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Context Therapeutics Revenue Highlights

00

Context Therapeutics Revenue by Period

Context Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Context Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Context Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$18.95K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

Context Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Context Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals$380.79M$416.00K
CHRSCoherus BioSciences$257.24M$70.77M
WVEWave Life Sciences$113.31M$19.69M
CTMXCytomX Therapeutics$101.21M$33.43M
SPROSpero Therapeutics$96.73M$13.47M
VECTVectivBio$27.34M$676.00K
BOLTBolt Biotherapeutics$7.88M$1.14M
ASMBAssembly Biosciences$7.16M$6.84M
CNTXContext Therapeutics--
XFORX4 Pharmaceuticals-$560.00K
GRCLGracell Bio--
DAWNDay One Biopharmaceuticals-$20.07M
ZURAZura Bio--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
NXTCNextCure--
INABIN8bio--
ANNXAnnexon--
NLTXNeurogene--
TERNTerns Pharmaceuticals--

CNTX Revenue FAQ

What is Context Therapeutics’s yearly revenue?

Context Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. CNTX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Context Therapeutics’s quarterly revenue?

Context Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). CNTX's quarterly revenue for Q4 2023 was $18.95K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Context Therapeutics’s revenue growth rate?

Context Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.